Regulated information – Inside information – UCB announced that the companies have entered into a definitive agreement under which UCB would acquire Zogenix, Inc.,...
Exelixis, Inc. (Nasdaq: EXEL) today announced results for cabozantinib (CABOMETYX®) in combination with immunotherapies in patients with advanced colorectal cancer, including encouraging data from...
ImmunityBio, Inc, a clinical-stage immunotherapy company, announced interim results (N=63) in its metastatic pancreatic cancer trial (QUILT 88) showing that the overall survival rate...
Focused on providing a streamlined pathway to fleet electrification, EV Connect announced the general availability of its Fleet Charging Management Platform. As a lead...
Silicon Valley Clean Energy (SVCE) is providing $100,000 in funding to EVmatch, a local electric vehicle (EV) charging software company, to support increased EV...
